|
ATCC
umr106 rat osteosarcoma cells ![]() Umr106 Rat Osteosarcoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/umr106+rat+osteogenic+sarcoma+cells/UMR-106%3B+Osteosarcoma%3B+Rat/pmc06711805-173-0-7 Average 93 stars, based on 1 article reviews
umr106 rat osteosarcoma cells - by Bioz Stars,
2026-09
93/100 stars
|
Buy from Supplier |
|
ATCC
umr 106 rat osteosarcoma cells ![]() Umr 106 Rat Osteosarcoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/umr106+rat+osteogenic+sarcoma+cells/UMR-106/pm09041048-37-0-4 Average 95 stars, based on 1 article reviews
umr 106 rat osteosarcoma cells - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
ATCC
cells rat osteoblastic osteosarcoma cells umr 106 ![]() Cells Rat Osteoblastic Osteosarcoma Cells Umr 106, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/umr106+rat+osteogenic+sarcoma+cells/Pfizer+Pneumococcal+polysaccharide+powder+Type+26/pm10544217-51-0-6 Average 91 stars, based on 1 article reviews
cells rat osteoblastic osteosarcoma cells umr 106 - by Bioz Stars,
2026-09
91/100 stars
|
Buy from Supplier |
|
iCell Bioscience Inc
rat os umr106 cell line ![]() Rat Os Umr106 Cell Line, supplied by iCell Bioscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/umr106+rat+osteogenic+sarcoma+cells/rat+os+cell+line+umr106/pm37634831-92-3-17 Average 90 stars, based on 1 article reviews
rat os umr106 cell line - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
European Collection of Authenticated Cell Cultures
rat-osteosarcoma cell line umr-106 ![]() Rat Osteosarcoma Cell Line Umr 106, supplied by European Collection of Authenticated Cell Cultures, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/umr106+rat+osteogenic+sarcoma+cells/rat+osteosarcoma+cell+line+umr+106/pmc09957231-195-0-4 Average 90 stars, based on 1 article reviews
rat-osteosarcoma cell line umr-106 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Procell Inc
rat osteosarcoma cells umr 106 ![]() Rat Osteosarcoma Cells Umr 106, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/umr106+rat+osteogenic+sarcoma+cells/cells+ishikawa/pmc12508912-387-5-10 Average 86 stars, based on 1 article reviews
rat osteosarcoma cells umr 106 - by Bioz Stars,
2026-09
86/100 stars
|
Buy from Supplier |
|
ATCC
autologous target cells ![]() Autologous Target Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/umr106+rat+osteogenic+sarcoma+cells/EL4/pm37584675-129-15-28 Average 97 stars, based on 1 article reviews
autologous target cells - by Bioz Stars,
2026-09
97/100 stars
|
Buy from Supplier |
|
ATCC
rat osteoblast like cell line ![]() Rat Osteoblast Like Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/umr106+rat+osteogenic+sarcoma+cells/Neurofibromatosis+Cell+Panel/pm25492008-46-1-7 Average 93 stars, based on 1 article reviews
rat osteoblast like cell line - by Bioz Stars,
2026-09
93/100 stars
|
Buy from Supplier |
|
LGC Standards
rat sarcomal osteoblasts ![]() Rat Sarcomal Osteoblasts, supplied by LGC Standards, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/umr106+rat+osteogenic+sarcoma+cells/Dibenzothiophen+(as+S)+in+iso-Octane/pm23359485-50-17-23 Average 94 stars, based on 1 article reviews
rat sarcomal osteoblasts - by Bioz Stars,
2026-09
94/100 stars
|
Buy from Supplier |
|
ATCC
rat osteosarcoma cells umr 106 ![]() Rat Osteosarcoma Cells Umr 106, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/umr106+rat+osteogenic+sarcoma+cells/TIBx%3B+Epithelial+liver%3B+Mouse/pm29229458-66-3-10 Average 97 stars, based on 1 article reviews
rat osteosarcoma cells umr 106 - by Bioz Stars,
2026-09
97/100 stars
|
Buy from Supplier |
|
BioResource International Inc
rat osteosarcoma umr-106 cell ![]() Rat Osteosarcoma Umr 106 Cell, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/umr106+rat+osteogenic+sarcoma+cells/rat+osteosarcoma+umr+106+cell/10__1007_slash_s10853___014___8717___y-59-0-7 Average 90 stars, based on 1 article reviews
rat osteosarcoma umr-106 cell - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Pflugers Archiv : European journal of physiology
Article Title: Connexin43 enhances Wnt and PGE2-dependent activation of β-catenin in osteoblasts
doi: 10.1007/s00424-019-02295-y
Figure Lengend Snippet: Left, Western blots of active β-catenin, phospho-Akt and connexin43 (Cx43) expression in primary mouse osteoblasts from Gja1flox/flox mice transduced with GFP (control) or Cre-recombinase expressing adenovirus. Right, Western blots of UMR106 osteoblasts transiently transfected with an empty vector control (neo) or a Cx43 overexpression plasmid. Cx43 was examined to validate deletion or overexpression, respectively. GAPDH was used as a loading control. Quantitation of independent experiments is shown below (means ± sd), n=3/group. *, p-value <0.05, **, p-value <0.01.
Article Snippet:
Techniques: Western Blot, Expressing, Transduction, Control, Transfection, Plasmid Preparation, Over Expression, Quantitation Assay
Journal: Pflugers Archiv : European journal of physiology
Article Title: Connexin43 enhances Wnt and PGE2-dependent activation of β-catenin in osteoblasts
doi: 10.1007/s00424-019-02295-y
Figure Lengend Snippet: (A)Western blots of active β-catenin in UMR106 cells osteoblasts transiently transfected with an empty vector control (neo) or a Cx43 overexpression plasmid and treated with Wnt3a (50ng/ml, 1 h) or Vehicle (Veh). GAPDH was used as a loading control. Images are from a single exposure of a contiguous membrane. Dotted lines indicate the removal of irrelevant lanes. Quantitation of independent western blotting experiments is shown to the right (means ± sd), n=3/group. *, p < 0.05, **, p < 0.01, ***, p < 0.001. (B) Luciferase reporter assay of β-catenin transcriptional activity from a TCF/Lef reporter (TOPflash) construct following treatment with vehicle (Veh) or Wnt3a (50ng/ml, 4 h). FOPflash contains mutated Tcf/Lef binding sites and represents a negative control. Results are presented as means ± sd, n=3/group. *, p < 0.05, **, p < 0.01, ***, p < 0.001; #, statistical interaction effect of the two variables (Cx43 and Wnt3a) by two-way ANOVA followed by Tukey’s multiple comparison test.
Article Snippet:
Techniques: Western Blot, Transfection, Plasmid Preparation, Control, Over Expression, Membrane, Quantitation Assay, Luciferase, Reporter Assay, Activity Assay, Construct, Binding Assay, Negative Control, Comparison
Journal: Pflugers Archiv : European journal of physiology
Article Title: Connexin43 enhances Wnt and PGE2-dependent activation of β-catenin in osteoblasts
doi: 10.1007/s00424-019-02295-y
Figure Lengend Snippet: (A)Western blots of active β-catenin, phospho-Akt, and phospho-GSK3β in UMR106 cells osteoblasts transiently transfected with an empty vector control (neo) or a Cx43 overexpression plasmid and treated with PGE2 (2μM, 1 h) or Vehicle (Veh). GAPDH was used as a loading control. Quantitation of independent western blotting experiments is shown to the right (means ± sd), n=3/group. *, p < 0.05, **, p < 0.01, ***, p < 0.001. (B) Luciferase reporter assay of β-catenin transcriptional activity from a TCF/Lef reporter (TOPflash) construct following treatment with vehicle (Veh) or PGE2 (2μM, 4 h). FOPflash contains mutated TCF/Lef binding sites and represents a negative control. Results are presented as means ± sd, n=3/group. *, p < 0.05, **, p < 0.01, ***, p < 0.001; #, statistical interaction effect of the two variables (Cx43 and PGE2) by two-way ANOVA followed by Tukey’s multiple comparison test.
Article Snippet:
Techniques: Western Blot, Transfection, Plasmid Preparation, Control, Over Expression, Quantitation Assay, Luciferase, Reporter Assay, Activity Assay, Construct, Binding Assay, Negative Control, Comparison
Journal: Pflugers Archiv : European journal of physiology
Article Title: Connexin43 enhances Wnt and PGE2-dependent activation of β-catenin in osteoblasts
doi: 10.1007/s00424-019-02295-y
Figure Lengend Snippet: (A)Western blots of active β-catenin, phospho-Akt, and phospho-GSK3β in UMR106 cells osteoblasts transiently transfected with an empty vector control (neo) or a Cx43 overexpression plasmid and treated with PGE2 (2μM, 1 h) or Vehicle (Veh) in the presence or absence of the PI3K inhibitor LY294002 (20μM, 30 min pre-treatment). GAPDH was used as a loading control. Quantitation of independent western blotting experiments is shown to below (means ± sd). *, p < 0.05 relative to the respective DMSO treated control. (B) Luciferase reporter assay of β-catenin transcriptional activity from a TCF/Lef reporter (TOPflash) construct following treatment with vehicle (Veh) or PGE2 (2μM, 4 h) in the presence or absence of the PI3K inhibitor LY294002 (20μM, 30 min pre-treatment). Results are presented as box and whisker plots (min to max), n=20/group. Statistical significance for the three variables (±Cx43, ±PGE2, and ±LY294002) was examined by three-way ANOVA followed by Holm-Sidak multiple comparison test. *, p < 0.05 relative to the respective DMSO treated control. Additional statistical comparisons are in Supplementary Table 1.
Article Snippet:
Techniques: Western Blot, Transfection, Plasmid Preparation, Control, Over Expression, Quantitation Assay, Luciferase, Reporter Assay, Activity Assay, Construct, Whisker Assay, Comparison
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Article Title: Rapid protein kinase A--mediated activation of cyclic AMP-phosphodiesterase by parathyroid hormone in UMR-106 osteoblast-like cells.
doi: 10.1359/jbmr.1997.12.2.172
Figure Lengend Snippet: FIG. 1. (A) Time-dependent effect of bPTH(1–84) on the PDE activity in UMR-106 cells. Control cells (E) and cells treated with 10 nM bPTH(1–84) (F) for indicated times were homogenized and assayed for PDE activity. (B) Con- centration-dependent activation of PDE activity in UMR- 106 cells. The cells were incubated with various concentra- tions of bPTH(1–84) for 20 minutes, homogenized, and assayed for PDE activity. ***p , 0.001, **p , 0.01 as compared with no PTH treatment.
Article Snippet:
Techniques: Activity Assay, Control, Activation Assay, Incubation
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Article Title: Rapid protein kinase A--mediated activation of cyclic AMP-phosphodiesterase by parathyroid hormone in UMR-106 osteoblast-like cells.
doi: 10.1359/jbmr.1997.12.2.172
Figure Lengend Snippet: FIG. 2. Effect of PKA inhibitor H-8 on bPTH(1–84) and forskolin (FSK)-stimulated PDE activation in UMR-106 cells. The PDE activity stimulated with 10 nM bPTH(1–84) or 5 mM forskolin for 20 minutes was almost completely abolished by H-8 treatment. **p , 0.01 compared with bPTH(1–84) and forskolin treatments with H-8.
Article Snippet:
Techniques: Activation Assay, Activity Assay
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Article Title: Rapid protein kinase A--mediated activation of cyclic AMP-phosphodiesterase by parathyroid hormone in UMR-106 osteoblast-like cells.
doi: 10.1359/jbmr.1997.12.2.172
Figure Lengend Snippet: FIG. 3. Effect of increasing concentrations of alkaline phosphatase (ALP) on the PDE activity of UMR-106 ho- mogenates. Control cells and cells stimulated for 20 min- utes with 10 nM bPTH(1–84) were homogenized and treated with increasing concentrations of ALP in homoge- nization buffer at 378C for 10 minutes. The ALP-treated homogenates were then assayed for PDE activity. The ef- fect of the ALP treatment was blocked with 50 mM of the ALP inhibitor L-phenylalanine (L-Phe).
Article Snippet:
Techniques: Activity Assay, Control
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Article Title: Rapid protein kinase A--mediated activation of cyclic AMP-phosphodiesterase by parathyroid hormone in UMR-106 osteoblast-like cells.
doi: 10.1359/jbmr.1997.12.2.172
Figure Lengend Snippet: FIG. 4. Sensitivity of homogenates from bPTH(1–84)- treated UMR-106 cells to specific PDE inhibitors. Cells stimulated with 10 nM bPTH(1–84) for 20 minutes were homogenized and assayed for PDE activity in the presence of increasing concentrations of the cAMP-PDE inhibitor RO 20-1724, cGI-PDE inhibitor milrinone, and cGS-PDE inhibitor MEP-1.
Article Snippet:
Techniques: Activity Assay
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Article Title: Rapid protein kinase A--mediated activation of cyclic AMP-phosphodiesterase by parathyroid hormone in UMR-106 osteoblast-like cells.
doi: 10.1359/jbmr.1997.12.2.172
Figure Lengend Snippet: FIG. 5. Distribution of PDE activity in soluble and par- ticulate fractions of homogenates from bPTH(1–84)- treated and control cells. UMR-106 cells were treated with 10 nM bPTH(1–84) for 20 minutes and homogenized. Sol- uble enzyme was separated from particulate enzyme by ultracentrifugation at 100,000g for 60 minutes. ***p , 0.001 as compared with control.
Article Snippet:
Techniques: Activity Assay, Control
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Article Title: Rapid protein kinase A--mediated activation of cyclic AMP-phosphodiesterase by parathyroid hormone in UMR-106 osteoblast-like cells.
doi: 10.1359/jbmr.1997.12.2.172
Figure Lengend Snippet: FIG. 6. Effect of the cAMP-PDE inhibitor RO 20-1724 (RO), cGI-PDE inhibitor milrinone, and PKA inhibitor H-8 on cAMP accumulation in UMR-106 cells. Cells were stimulated with 10 nM bPTH(1–84) (A) or 1 mM forskolin (B) for 10 minutes in the presence of inhibitors and assayed for cellular cAMP. ***p , 0.001, **p , 0.01 as compared with control.
Article Snippet:
Techniques: Control